Anthony Manning
Fortune : 10 108 $ au 31/05/2026
Fortune : 10 108 $ au 31/05/2026
Anthony M.
Manning is the founder of Institute For Biomedical Entrepreneurship, Inc. Current positions include Independent Director at Monte Rosa Therapeutics, Inc. since 2023 and Principal at Manning Bio Worldwide LLC.
Former roles include Independent Director at Palatin Technologies, Inc., Head-Research at Celgene Corp., Vice President & Head-Autoimmune Diseases Research at Biogen, Inc. from 2007 to 2011, Principal at Signal Pharmaceuticals, Inc., Vice President & Global Head-Inflammation at Roche Pharmaceuticals, Inc. from 2002 to 2007, Senior Vice President-Research at Momenta Pharmaceuticals, Inc., SVP-Research & Preclinical Development at Rein Therapeutics, Inc. from 2011 to 2013, and Vice President at Pharmacia Corp.
from 2000 to 2002.
Education includes a doctorate from the University of Otago conferred in 1990.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/06/2025 | 721 ( 0,04 % ) | 10 108 $ | 31/05/2026 | |
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 25/07/2023 |
Institute For Biomedical Entrepreneurship, Inc. | Fondateur | - |
| Sociétés | Poste | Fin |
|---|---|---|
| REIN THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/01/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/04/2011 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01/08/2007 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01/01/2002 |
| MOMENTA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Palatin Technologies, Inc.
Palatin Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines based on molecules for the modulation of melanocortin receptor system | Health Technology |
Signal Pharmaceuticals, Inc.
Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Commercial Services |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Rein Therapeutics, Inc.
Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
University of Otago
University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Institute For Biomedical Entrepreneurship, Inc. | |
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national